drugset
drugset / Trial / NCT02929264

An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates

NCT02929264 ↗

Phase 1 Completed 16 enrolled Abide Therapeutics University of Oxford · collab
RandomizedCrossoverTriple-blindBasic science

Summary

An fMRI study in healthy volunteers to investigate the effects of ABX-1431 on experimental hyperalgesia and its neural correlates.

Timeline

Start
2016-12
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ABX-1431 Small molecule 40 mg —

Indications

No indication recorded.